- Home
- FRBA vs RCKT Comparison
FRBA vs RCKT Comparison
Compare FRBA & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRBA
- RCKT
- Stock Information
- Founded
- FRBA 2007
- RCKT 1999
- Country
- FRBA United States
- RCKT United States
- Employees
- FRBA N/A
- RCKT N/A
- Industry
- FRBA Major Banks
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- FRBA Finance
- RCKT Health Care
- Exchange
- FRBA Nasdaq
- RCKT Nasdaq
- Market Cap
- FRBA 323.4M
- RCKT 326.4M
- IPO Year
- FRBA N/A
- RCKT N/A
- Fundamental
- Price
- FRBA $14.59
- RCKT $2.70
- Analyst Decision
- FRBA Buy
- RCKT Buy
- Analyst Count
- FRBA 1
- RCKT 13
- Target Price
- FRBA $17.00
- RCKT $18.50
- AVG Volume (30 Days)
- FRBA 42.0K
- RCKT 8.4M
- Earning Date
- FRBA 07-23-2025
- RCKT 08-04-2025
- Dividend Yield
- FRBA 1.65%
- RCKT N/A
- EPS Growth
- FRBA 36.40
- RCKT N/A
- EPS
- FRBA 1.54
- RCKT N/A
- Revenue
- FRBA $128,402,000.00
- RCKT N/A
- Revenue This Year
- FRBA $5.45
- RCKT N/A
- Revenue Next Year
- FRBA $5.95
- RCKT N/A
- P/E Ratio
- FRBA $9.47
- RCKT N/A
- Revenue Growth
- FRBA 21.15
- RCKT N/A
- 52 Week Low
- FRBA $11.68
- RCKT $2.19
- 52 Week High
- FRBA $15.87
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- FRBA 48.01
- RCKT 32.09
- Support Level
- FRBA $14.34
- RCKT $2.66
- Resistance Level
- FRBA $15.29
- RCKT $3.33
- Average True Range (ATR)
- FRBA 0.27
- RCKT 0.28
- MACD
- FRBA -0.04
- RCKT 0.09
- Stochastic Oscillator
- FRBA 32.04
- RCKT 26.59
About FRBA First Bank
First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of businesses. Its services are Business Banking; Personal banking; Digital Banking; and Lending.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.